Older hospitalized acute decompensated heart failure (HF) patients have persistently poor outcomes and delayed recovery regardless of ejection fraction (EF). We hypothesized that impairments in physical function, frailty, cognition, mood, and quality of life (QoL) potentially contributing to poor clinical outcomes would be similarly severe in acute decompensated HF patients ≥60 years of age with preserved versus reduced EF (HFpEF and HFrEF).
T
he burden of heart failure (HF) is increasing in the United States particularly among older adults, who comprise the majority of the HF population. 1 Acute decompensated HF (ADHF) is a leading cause of hospitalization among older Americans, and hospitalization is associated with markedly adverse outcomes, including increased mortality, morbidity, and health care expenditures. [2] [3] [4] While these outcomes have received considerable attention, less is known about key patient-centered outcomes of physical function, frailty, cognition, depression, and quality of life (QoL) among older ADHF which are important to patients independent of mortality, and are also strong predictors of clinical events. 5 In a small study of older hospitalized ADHF patients, we previously found severe impairments in multiple domains of physical function, including balance, strength, mobility, and endurance, and these were accompanied by high rates of frailty, cognitive dysfunction, and depression and were associated with poor QoL. 6 These impairments were much more severe than those observed in age-matched patients with chronic stable HF and were similar in severity to patients with advanced HF awaiting left ventricular assist device implantation. 7 It has been shown by our group and others that these impairments, which are often unrecognized and not addressed by current care pathways, could help account for the persistently poor outcomes after hospitalization among older ADHF patients. [8] [9] [10] However, the sample size in our pilot study was very small (n=27), limiting confidence in the point estimates and generalizability of our results, as well as precluding subgroup analyses. 10 Among subgroups of older ADHF patients, HF with preserved ejection fraction (HFpEF) is the most important phenotype. HFpEF is the most common form of HF in the elderly, accounting for ≈90% of incident HF among older women. 11 The cardiovascular substrate of HFpEF differs significantly from HF with reduced EF (HFrEF), and the pathophysiology of HFpEF is not well understood. Furthermore, responses to interventions in chronic HFpEF frequently diverge markedly from those of HFrEF, where many therapies proven highly effective for HFrEF have shown little or no benefit for HFpEF. 12 After ADHF, all-cause outcomes for HFpEF are similarly adverse as for HFrEF but with differences in HF diseasespecific outcomes. 3 The mechanisms contributing to these outcomes are not well understood.
In older adults in general, severe physical impairments and accompanying frailty, cognitive impairment, depression, and diminished QoL are associated with adverse clinical outcomes 8, 13, 14 but, to our knowledge, there is no previous report comparing these key patient-centered outcomes in older adults with acute decompensated HFpEF versus HFrEF. Accordingly, we performed prospective, comprehensive assessments at baseline in 202 consecutive patients in the National Institutes of Health-funded, multicenter REHAB-HF trial (Rehabilitation Therapy in Older Acute Heart Failure Patients). We hypothesized that impairments in physical function, frailty, cognitive function, depression, and QoL would be similarly severe across all assessments in ADHF patients ≥60 years of age with preserved versus reduced EF (HFpEF and HFrEF).
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METHODS
Inclusion and Exclusion Criteria
The present study is a cross-sectional analysis of the baseline assessment of the first n=202 consecutively enrolled participants in the REHAB-HF clinical trial. Full details about REHAB-HF trial design have been published. 15, 16 We recruited patients at 7 sites ≥60 years old and hospitalized for at least 24 hours with ADHF. HFrEF was defined as EF <45% and HFpEF was defined as EF ≥45% based on the REHAB-HF trial protocol. For the purposes of this analysis, we also conducted comparisons using more contemporary 3 EF categories, which also includes HF with borderline EF: EF ≤35%, EF >35% to <50%, and EF ≥50%. EF was assessed during the course of clinical care via echocardiogram, magnetic resonance imaging, cardiac catheterization, or nuclear medicine scan and was
WHAT IS NEW?
• Hospitalized, older (≥60 years) acute decompensated heart failure (HF) patients with both preserved and reduced ejection fraction have severe impairments across multiple patient-centered outcomes, including physical function, quality of life, cognition, and depression.
• HF with preserved ejection fraction and HF with reduced ejection fraction patients show similar degrees of impairment in physical function, including endurance, strength, balance, and mobility, and high rates of cognitive impairment and frailty.
• Despite these similarities, HF with preserved ejection fraction patients report worse quality of life and higher burden of depression.
WHAT ARE THE CLINICAL IMPLICATIONS?
• These patient-centered outcomes are of independent importance and strongly associated with clinical outcomes.
• However, these impairments are not addressed by current acute decompensated heart failure care models. • These findings suggest opportunities for novel interventions and multidimensional care models to improve clinical outcomes, functional status, and quality of life in older patients recovering from acute decompensated heart failure across HF phenotypes.
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Study Variables
Assessments were collected during hospitalization, after successful initial treatment for ADHF and clinical stability had been achieved and before hospital discharge. A trained assessor using a standardized protocol assessed all physical function measures, which included the short physical performance battery (SPPB), 6-minute walk distance (6MWD), and handgrip strength. The SPPB is a well-established, standardized, reproducible measure of physical function in older patients that strongly predicts key clinical outcomes, including hospitalization, death, and nursing home placement. 13 The 3 components of the SPPB are static standing balance, 4-meter walk time, and time to complete 5 repeated chair stands. Each component is scored from 0 to 4, for a total score of 0 to 12; patients with a score of <10 are considered at high risk for mobility disability with lower score identifying progressively higher risk. [17] [18] [19] [20] The 6MWD was assessed in an unobstructed hallway. Participants were allowed to use an assist device if needed. A distance of ≤300 meters identifies patients with severe functional impairment. 21 Frailty phenotype was assessed as previously described 10,22 based on domains originally described by Fried (slowness [gait speed], weakness [hand grip], weight loss, exhaustion, and low physical activity). 23 Gait speed, a component of both the SPPB and Fried frailty phenotype, is also of independent importance with <0.8 m/s identifying patients at increased risk for disability and mortality that increases incrementally with each 0.1 m/s additional reduction in gait speed. 19, 20 Handgrip strength was assessed using a hand dynamometer. Weak handgrip has been associated with increased risk of poor clinical outcomes 8, 24 ; recommended cutoffs for weakness are <28.5 kg in men and <18.5 kg in women. 25 Cognitive function was assessed using the Montreal Cognitive Assessment with a score of <26 indicating at least mild cognitive impairment. 26 A score of ≥5 on the Geriatric Depression Scale 15-item survey (GDS-15) was considered consistent with depression. 27 Clinical diagnosis of depression was based on documentation of the diagnosis in the medical record. QoL was assessed using the Kansas City Cardiomyopathy Questionnaire (Overall and Physical Limitation Scores), the Short Form-12 (physical and mental composite scores) and EuroQol-5D-5L.
Statistical Analysis
Categorical variables were analyzed as frequencies (percentages) and group differences were compared using the χ 2 test. Continuous variables were compared by t test and presented as mean±SD if normality assumptions appeared to be reasonable. BNP and NT-ProBNP were log-transformed before analysis. Highly skewed continuous variables were analyzed using nonparametric Wilcoxon rank-sum tests in unadjusted analyses. Negative binomial regression was used for count data (eg, hospitalizations). Because of significant differences between patient groups, adjusted analyses were conducted to control for potential confounders that may affect physical function and QoL; these included sex, body mass index (BMI), nonwhite race, and comorbidities. We did not adjust GDS score for comorbidities given collinearity between GDS and clinical depression. For continuous variables, ANCOVA was used and least square means based on observed sample margins were presented in adjusted analysis. Rank transformed ANCOVA was used for group comparisons for highly skewed continuous variables. Similarly, binary variables were adjusted using logistic regression for sex, BMI, nonwhite race, and comorbidities. Adjusted proportions and associated 95% CIs were estimated using nonlinear contrasts. Group differences and 95% CIs were reported in all adjusted analyses. Pearson correlation coefficients were used to assess the relation between QoL and depression measures. In the primary analysis, EF categories were derived from the parent trial: EF <45% and EF ≥45%. We also replicated the primary analysis using 3 EF categories: EF ≤35%; EF >35% and <50%; and EF ≥50%. Additional details about statistical methods for this analysis are provided in the Data Supplement. Two-tailed P value <0.05 was considered significant. All analyses were performed using SAS Enterprise Guide 7.1 (Cary, NC).
RESULTS
Participant Characteristics
A total of 202 consecutively enrolled patients from September 2014 to February 2017 and were included in this analysis. HFpEF patients represented 48% (n=96/202) of the population and were more likely to be female, white, have not graduated high school and have higher BMI than patients with HFrEF; there was no difference in age (Table 1) . HFpEF patients were less likely to have been hospitalized for HF within 6 months before enrollment and were more likely to be hospitalized for non-HF causes than HFrEF patients. Comorbidities were frequent in both groups (mean >5), with HFpEF patients having a higher burden of overall comorbidities than HFrEF patients, including more arthritis/connective tissue disease, obstructive sleep apnea, and depression. Patients with HFpEF were less likely to be on β-blockers and angiotensin-converting enzyme inhibitors and had higher calcium channel blocker use.
Physical Function, Frailty, and Cognitive Function
Both older acute HFpEF and HFrEF had physical function impairments in all domains (balance, mobility, strength, and endurance). Performance score on the SPPB, gait speed, 6MWD, and handgrip strength was well below recognized cutoffs for poor performance associated increased risk (Table 2 ). For context, in the overall study population, balance deficits rendered 36% unable to attempt tandem stance (one foot directly in front of the other, heel to toe) and lower extremity weakness rendered 25% unable to stand even once from a chair without assistance. For comparison, in a prior analysis of subjects of similar age range, such deficits were present in only 6% to 7% of chronic HF patients and in no healthy adults. 6 Additionally, we found that 79% of older ADHF patients had impaired mobility based on slow gait (<0.8 m/s), 85% had severely reduced endurance (6MWD <300 m), and 34% had generalized weakness based on low grip strength. Unadjusted SPPB score, 6MWD, and gait speed were significantly lower in HFpEF than HFrEF. However, these between-group differences were no longer observed after adjusting for intergroup differences in sex, race, BMI, and comorbidities (Table 2; Figure 1 ). Overall, 53% of patients met formal criteria for physical frailty, Values presented as frequency (%) or mean±SD unless otherwise indicated. Anemia was defined as hemoglobin <12 g/dL for women or <13 g/dL for men. HIV/AIDS was determined by medical record. ADHF indicates acute decompensated heart failure; BMI, body mass index; CABG, coronary artery bypass surgery; EF, ejection fraction; HF, heart failure; HFpEF, heart failure with preserved ejection fraction; HFrEF, heart failure with reduced ejection fraction; IQR, interquartile range; MI, myocardial infarction; and PCI, percutaneous coronary intervention. Unadjusted values shown as mean±SD or frequency (%). Adjusted values shown as LSmean±SE or percent (95% CI), adjusted for sex, race, and BMI and total number of comorbidities. For KCCQ, SF-12 and Visual Analog Scale, higher score indicates better health status; for EQ-5D components higher score indicates worse health status. ADHF indicates acute decompensated heart failure; BMI, body mass index; EQ-5D-5L, EuroQol-5D-5L; HF, heart failure; HFpEF, heart failure with preserved ejection fraction; HFrEF, heart failure with reduced ejection fraction; KCCQ, Kansas City Cardiomyopathy Questionnaire; MCS, mental composite score; MoCA, Montreal Cognitive Assessment; PCS, physical composite score; and SPPB, short physical performance battery.
*Adjusted for sex, race, and BMI only.
(n=65) had symptomatic depression based on GDS ≥5 with no clinical recognition of depression in the medical record. Further, presence of depression strongly predicted poor QoL, based on significant correlations of the GDS score with QoL measures (Kansas City cardiomyopathy questionnaire, r=−0.58 and SF-12 physical composite score, r=−0.63; Table 3 ). HF-specific (Kansas City cardiomyopathy questionnaire) and general QoL (SF-12; EuroQol-5D-5L) were reduced in both groups; in unadjusted analyses, QoL was worse in HFpEF patients and remained so in adjusted analyses (Table 2; Figure 1 ). This included self-reported walking difficulty, which, consistent with objective assessments of impairments in physical function, was common (≥75%) in both groups, more frequent in HFpEF patients in the unadjusted analysis and similar in the adjusted analysis (Table 2 ). However, difficulty with self-care was nearly twice as frequent in HFpEF patients ( Figure 2 ) and self-care difficulties remained greater in HFpEF patients even after adjustments (Table 2 ).
Analysis With 3 EF Categories
In the supplemental analysis comprised 3 EF categories (35% [HFrEF; n=86]; >35% and <50% [HF with borderline EF; n=28]; and ≥50% [HFpEF; n=88]), adjusted differences between the groups were largely consistent with the primary analysis except that significant between-group differences in GDS were no longer noted (Tables 1 through 3 
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DISCUSSION
Within an ongoing multicenter trial, we prospectively conducted a comprehensive assessment of multiple key patient-centered outcomes relating to physical function, frailty, cognition, depression, and QoL in 202 Values adjusted for sex, race, body mass index (BMI), and total comorbidities, except geriatric depression scale score (GDS), which was adjusted for sex, race, and BMI only. 6MWD indicates 6-minute walk distance; EF, ejection fraction; HF, heart failure; HFpEF, heart failure with preserved ejection fraction; HFrEF, heart failure with reduced ejection fraction; KCCQ, Kansas City Cardiomyopathy Questionnaire; and SPPB, short physical performance battery. EQ-5D-5L indicates EuroQol-5D-5L; KCCQ, Kansas City Cardiomyopathy Questionnaire; MCS, mental composite score; and PCS, physical composite score.
consecutive patients ≥60 years hospitalized with ADHF and analyzed outcomes by HF phenotype (HFpEF versus HFrEF). We found broad, marked impairments in all domains of physical function-balance, strength, mobility, and endurance. Approximately 50% of patients met formal criteria for physical frailty, >75% had significant cognitive impairment, ≈50% had significant depressive symptoms, and HF-specific and general QoL were severely reduced. Consistent with our hypothesis, physical dysfunction, frailty, and cognitive impairments were similar in HFpEF versus HFrEF when adjusted for differences in sex, race, BMI, and comorbidities. However, depression appeared to be more common or severe in HFpEF. Importantly, the majority of depression in both HFpEF and HFrEF appeared to be clinically unrecognized. Health-related QoL (HF-specific and general) was consistently worse in HFpEF patients and remained so after adjustment.
To our knowledge, these patient-centered outcomes have not previously been systematically and comprehensively assessed in the large and growing high risk population of older adults with ADHF and examined by EF subtypes, particularly HFpEF which is the most common among older patients. We also selected an age cutoff (≥60 years) that is inclusive of the vast majority of HF patients. These findings are valuable in that each of these impairments is clinically meaningful, has independent prognostic importance, and is usually not addressed in current care models or disease management pathways. 21 Prior reports in older hospitalized patients in general indicated that these types of impairments are strong, independent predictors of rehospitalization, nursing home placement, and allcause mortality. 8, 29 A large recent study reported that, surprisingly, the majority of rehospitalizations in older ADHF patients are not for recurrent HF. 3 Thus, these data provide potentially valuable insights and facilitate the development of novel interventions and care models targeting these impairments, as discussed below. Doing so has the potential to improve patient-centered outcomes as well as clinical event rates adjudicated by changes in these outcomes.
Frailty, present in >50% of both HFpEF and HFrEF patients, was much more common in ADHF than observed in chronic stable HF patients (≤20%) and is particularly notable given the inclusion of patients aged 60 to 69 years where lower frailty rates would be expected. 6, 8, 22 Physical function impairments likely account for the high frailty rates we observed. Impairments were present across all domains (endurance, strength, balance, and mobility) and were similarly severe in HFrEF and HFpEF, despite different underlying cardiovascular substrates. These included 6MWD that was approximately half that reported in chronic HF, weakness such that 25% were unable to stand unassisted from a chair even once, and difficulties in balance and mobility not typically seen in chronic HF patients. 6, 7, 30 The severity and breadth of impairments are also notable given that assessments were conducted after successful treatment for the acute HF decompensation in patients who were deemed nearing readiness for discharge to home and excluding those requiring subacute rehabilitation.
The severity and breadth of impairments are likely because of the combined effects of preexisting impairments from aging, chronic HF, comorbidities, and chronic skeletal muscle abnormalities common to HFpEF and HFrEF, including reduced muscle mass, adipose infiltration, shift in fiber type, reduced capillary density, and mitochondrial dysfunction. 31, 32 These are likely additionally compounded by the systemic effects of ADHF mediated through activation of inflammatory and neurohumoral pathways, hospital-associated immobility (older hospitalized patients spend >80% of time lying in bed and <5% ambulating 33 ), and skeletal myopathy that progresses rapidly after hospitalization (Figure 3) . 34 These findings have important implications for physical rehabilitation interventions for recently hospitalized, older ADHF patients. Standard, endurance-based cardiac rehabilitation improves physical function and QoL in chronic stable HFrEF and may provide similar benefit in chronic, stable HFpEF. [35] [36] [37] However, cardiac rehabilitation is not approved for Medicare reimbursement in patients with ADHF or a recent hospitalization because of a lack of evidence supporting its safety or efficacy 38, 39 and is not approved at all for HFpEF. 39 Furthermore, conventional cardiac rehabilitation does not usually address the broad impairments in balance, mobility, and functional strength we identified in these frail patients ≥60 Figure 2 . EuroQol-5D-5L (EQ-5D-5L) dimensions of self-reported mobility and self-care in older hospitalized patients with acute decompensated heart failure (ADHF). P value represents difference in frequency of problem of any severity. EF indicates ejection fraction; HF, heart failure; HFpEF, heart failure with preserved ejection fraction; and HFrEF, heart failure with reduced ejection fraction.
years of age. For example, 40% of HFpEF patients in our study were unable to even attempt tandem stance because of severe balance deficits, 89% reported difficulty with walking, and 60% had difficulty with self-care. Thus, even if eligible for Medicare coverage, these patients are likely ill-suited for standard cardiac rehabilitation. Indeed, it has been shown in other older frail populations that undertake endurance-based rehabilitation without first addressing these deficits may increase the risk of injuries. 40 Thus, addressing these marked, wide-spread physical function deficits in ADHF patients may require a tailored physical rehabilitation intervention addressing deficits in balance, mobility, strength, and endurance, as is being testing in the ongoing, National Institutes of Health-funded, REHAB-HF trial, of which a subset of cross-sectional data is presented here. 15 Clinically important impairments were not limited to the physical function. Cognitive impairment was present in >75% of the cohort and may be linked to physical frailty through common underlying mechanisms, including complex interplay of neurohormonal, inflammatory, hemodynamic, and nutritional pathways. 41 This may limit patients' ability to adhere to complex self-care and medication regimens 38, 42 and is independently associated with adverse outcomes.
14 However, cognitive impairment is often unrecognized and has not been accounted for or addressed in conventional HF care pathways and models. Recognition of difficulties in self-care and cognition could lead to increased use of specific strategies such as support systems within transitional care programs, which could potentially improve outcomes. 43 Similarly, depression was common and generally under-recognized clinically by ≈ 50%. The lack of focus on depression may in part be because of the lack of benefit from standard pharmacotherapy in depressed HF patients. 44 However, these trials did not include HFpEF patients, in whom our findings suggest depression may be more frequent and more severe, at least in the context of ADHF. Additionally, non-pharmacological therapies, such as exercise training and cognitive behavior therapy, have shown promise in alleviating depression in HF patients, 45, 46 supporting that depression in HF patients may be amenable to alternative treatment modalities.
Depression is strongly linked to poor health status in older HF patients [47] [48] [49] and QoL was worse in HFpEF versus HFrEF by all 3 QoL instruments used, despite similar impairments in physical function, cognition, and frailty. For perspective, global QoL reported by HFpEF patients is nearly identical to ambulatory end-stage HFrEF patients for whom left ventricular assist device therapy may be justified (53 and 52 out of 100, respectively). 50 Difficulties in self-care and consequent loss of independence were more frequent in HFpEF versus HFrEF and may also have contributed to the lower QoL since these are important determinants of QoL among older adults. EF indicates ejection fraction; HFpEF, heart failure with preserved ejection fraction; HFrEF, heart failure with reduced ejection fraction; and QoL, quality of life.
Overall, these findings support a more comprehensive and multidimensional approach to the care of older patients hospitalized with ADHF irrespective of EF, such as that recently described by Gorodeski et al. 8, 51 This model addresses impairments in physical function, cognition, mood, and social support needs in addition to medical management of HF and comorbidities. Ultimately, such an approach could help reduce the posthospital syndrome, associated with delayed and incomplete recovery and frequent rehospitalization and death experienced by >70% of older HFrEF and HFpEF patients within 1-year posthospitalization, at least half of which are because of noncardiac causes. 
Limitations
The study cohort was limited to patients eligible for participation in a clinical trial. However, the trial inclusion/exclusion criteria were specifically designed to be broadly inclusive of typical older, frail ADHF patients with multiple comorbidities. 15 Additionally, HFpEF patients were more likely to be female, white, have higher BMI, and greater comorbidity burden than patients with HFrEF, which is in accord with reports from population-based studies, 53 supporting the generalizability of these results. The severity and breadth of impairments are consistent with previous reports, including observational cohorts 8, 29 further supporting generalizability. It is possible we underestimated the severity because the trial excluded patients who were expected to be discharged to a rehabilitation or skilled nursing facility. Given the cross-sectional study design, we cannot assess the relative importance of these impairments to subsequent outcomes, although prior research indicates these impairments strongly predict subsequent clinical events. Finally, we cannot exclude potential residual confounding causing observed differences in patients by HF phenotype.
Conclusions
Hospitalized ADHF patients ≥60 years of age had markedly impaired physical function and high rates of frailty and cognitive impairments, and these were similar in HFpEF versus HFrEF. QoL was severely reduced and depression was common and both were worse in HFpEF than HFrEF. These findings may help explain the high frequency of posthospital syndrome, 52 delayed recovery, and rehospitalization and suggest opportunities for novel interventions to improve the persistently poor outcomes in hospitalized older ADHF patients.
